Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
According to The Migraine Trust, there are approximately 190,000 migraine attacks in the UK every day. Now, a new device that sends magnetic impulses to the brain could help combat the condition, and has been recommended as a treatment by the UK's National Institute for Health Care and Excellence.
There are two types of the condition - migraine with aura and migraine without aura.
Migraine with aura means the condition is accompanied by visual disturbances, including blind spots, tunnel vision and even temporary blindness. Sufferers can also experience numbness or tingling, dizziness, weakness or vertigo.
What exactly causes a migraine is unknown, but health professionals say the condition may be triggered by a series of factors, including the environment, stress, alcohol, lack of food, lack of sleep, and - in women - hormonal changes.
Migraine symptoms usually last between 4 and 72 hours, meaning the condition may impact a person's family, work or social lives.
Now, the UK's National Institute for Health and Care Excellence (NICE) has revealed the results of a series of clinical trials involving a portable handheld device, which researchers say could "transform lives" of migraine sufferers.
The device works by sending transcranial magnetic stimulation (TMS) - brief magenetic impulses - to the brain at the press of a button.
In one study of 164 migraine sufferers, the patients were treated with a single TMS using the device, for a minimum of one migraine attack with aura.
Researchers found that 2 hours after the onset of the migraines, 39% of patients were free of pain. At 24 hours, 29% were pain free, while 27% were pain free at 48 hours.
Results of another study revealed that approximately 75% of patients who received repetitive treatment with the device demonstrated a reduction in the frequency of headaches, and this was evident even in individuals with chronic migraine.
One patient, who had suffered headaches at least every other day, notes that the device has enabled her to go up to 10 days without experiencing a headache and has reduced her intake of painkillers.
Based on these results, NICE have issued recommendations stating that the device may be used as a treatment option for patients who suffer migraines.
These recommendations come shortly after the US Food and Drug Administration (FDA) approved a similar device - called the Cerena Transcranial Magnetic Simulator - for the treatment of migraines at the end of last year.
Researchers say the device may be useful for patients who find current treatment methods, such as painkillers and anti-inflammatory medicines, unsuitable. Pregnant women fall into this category, as they are advised to limit their medicinal use for migraines.
Commenting on the recommendations, Dr. Fayyaz Ahmed, a consultant Neurologist and a trustee of UK charity The Migraine Trust, says:
"This is a breakthrough treatment for those who cannot tolerate or do not respond to current treatment, and opens the door for a new era in treating migraine headaches.
We welcome NICE guidance and very much hope this treatment is made available to those in need."
According to The Migraine Trust, UK residents can try the device by asking their doctor for a referral to a specialist migraine and headache clinic.
Last year, Medical News Today reported on a study detailing the discovery of several genetic regions in the brain that may be responsible for triggering migraine attacks.
Written by Honor Whiteman
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
News release from The Migraine Trust, accessed 21 January 2014.
Visit our Headache / Migraine category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Whiteman, Honor. "Portable magnetic stimulation device 'effective' against migraines." Medical News Today. MediLexicon, Intl., 22 Jan. 2014. Web.
7 Mar. 2014. <http://www.medicalnewstoday.com/articles/271487>
Whiteman, H. (2014, January 22). "Portable magnetic stimulation device 'effective' against migraines." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/271487.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.